These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 34162126)
1. A risk signature with inflammatory and immune cells infiltration predicts survival and efficiency of chemotherapy in gastric cancer. Li S; Sun S; Sun H; Ma P; Zhang J; Cao Y; Liu C; Zhang X; Wang W; Li Z; Ma Y; Xue Y; Zhao Y Int Immunopharmacol; 2021 Jul; 96():107589. PubMed ID: 34162126 [TBL] [Abstract][Full Text] [Related]
2. Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer. Jiang Y; Xie J; Huang W; Chen H; Xi S; Han Z; Huang L; Lin T; Zhao LY; Hu YF; Yu J; Cai SR; Li T; Li G Cancer Immunol Res; 2019 Dec; 7(12):2065-2073. PubMed ID: 31615816 [TBL] [Abstract][Full Text] [Related]
3. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer. Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X Front Immunol; 2020; 11():621623. PubMed ID: 33613554 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the infiltration of CD163 Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574 [TBL] [Abstract][Full Text] [Related]
5. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566 [TBL] [Abstract][Full Text] [Related]
6. A Risk Signature With Inflammatory and T Immune Cells Infiltration in Colorectal Cancer Predicting Distant Metastases and Efficiency of Chemotherapy. Hu X; Li YQ; Ma XJ; Zhang L; Cai SJ; Peng JJ Front Oncol; 2019; 9():704. PubMed ID: 31456937 [TBL] [Abstract][Full Text] [Related]
7. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
8. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752 [TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer. Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128 [TBL] [Abstract][Full Text] [Related]
10. Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer. Carus A; Ladekarl M; Hager H; Nedergaard BS; Donskov F Br J Cancer; 2013 May; 108(10):2116-22. PubMed ID: 23591202 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil infiltration is a favorable prognostic factor in early stages of colon cancer. Wikberg ML; Ling A; Li X; Öberg Å; Edin S; Palmqvist R Hum Pathol; 2017 Oct; 68():193-202. PubMed ID: 28882699 [TBL] [Abstract][Full Text] [Related]
12. Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis. Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559 [TBL] [Abstract][Full Text] [Related]
13. CD66b Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331 [TBL] [Abstract][Full Text] [Related]
14. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682 [No Abstract] [Full Text] [Related]
15. Intratumoral Foxp3 Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826 [TBL] [Abstract][Full Text] [Related]
16. The Interplay Between Neutrophils and CD8 Governa V; Trella E; Mele V; Tornillo L; Amicarella F; Cremonesi E; Muraro MG; Xu H; Droeser R; Däster SR; Bolli M; Rosso R; Oertli D; Eppenberger-Castori S; Terracciano LM; Iezzi G; Spagnoli GC Clin Cancer Res; 2017 Jul; 23(14):3847-3858. PubMed ID: 28108544 [No Abstract] [Full Text] [Related]
17. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation. Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497 [TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer. Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485 [TBL] [Abstract][Full Text] [Related]
19. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer. He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005 [TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer. Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]